Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Gsk Plc (GS71.DE)

Weekly Buzz: GH, LLY Gain FDA Nod; TEVA, GSK, Lead M&A Wave; ZEAL, LLY Post Strong Data 6/12/2026 11:36:49 AM

GSK Receives FDA And EMA Orphan Drug Designations For Momelotinib In VEXAS Syndrome 6/12/2026 6:02:06 AM

GSK: Momelotinib Granted Orphan Drug Designations In The US, EU 6/12/2026 2:22:19 AM

GSK Says FDA And EMA Grant Orphan Drug Designation To Momelotinib For VEXAS Syndrome 6/12/2026 2:06:05 AM

GSK: FDA & EMA Grant Orphan Drug Designation To Momelotinib For VEXAS Syndrome 6/12/2026 2:02:36 AM

Nuvalent Stock Climbs 39% On $10.6 Bln Takeover Deal With GSK 6/9/2026 8:05:15 AM

GSK Strikes $10.6B Nuvalent Deal Strengthening Targeting Cancer Pipeline 6/9/2026 3:25:39 AM

GSK To Acquire Nuvalent For $124/shr; To Be Accretive To Core EPS In 2029 6/9/2026 2:29:19 AM

GSK Agrees To Acquire Nuvalent For $10.6 Bln 6/9/2026 2:05:10 AM

GSK Reportedly In Talks To Buy Nuvalent For Over $9 Bln 6/9/2026 1:06:28 AM

Weekly Buzz: AZN, JNJ Get FDA Nod; LLY To Acquire Curevo; APGE Advances Zumilokibart 5/29/2026 10:39:40 AM

GSK Says Bepirovirsen Achieves Phase III Functional Cure Goal In Chronic Hepatitis B 5/28/2026 12:39:13 PM

GSK Reports Positive Pivotal Data For Bepirovirsen In Chronic Hepatitis B 5/28/2026 10:43:32 AM

GSK: Japan's MHLW Expands Eligible Population For Arexvy 5/18/2026 2:22:55 AM

GSK's RSV Vaccine Arexvy Gets Expanded Approval In Japan For Adults Aged 18-59 At Increased Risk 5/18/2026 2:10:42 AM

GSK Launches Final GBP 0.18 Bln Tranche Of GBP 2 Bln Share Buyback 5/11/2026 3:31:58 AM

GSK Plc Announces Final Tranche Of £2 Bln Share Buyback Programme 5/11/2026 2:04:36 AM

GSK Licenses Halozyme's ENHANZE Drug Delivery Technology 5/7/2026 9:31:00 AM

GSK Q1 Core Profit Rises; Affirms 2026 Guidance 4/29/2026 2:35:46 AM

GSK Q1 Total EPS 43.2p; Core EPS 46.5p 4/29/2026 2:05:04 AM

- 1
- 2
- 3
- Next »

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap